BackLexeo Therapeutics Overview

Lexeo Therapeutics Current Cash

Lexeo Therapeutics's current cash is $72M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$71.77M
↑ 148.22% YoYΔ $42.85M vs prior year quarter

Peer average

Loading

Lexeo Therapeutics Current Cash History

Loading

Lexeo Therapeutics vs. peers: Current Cash Comparison

Loading

Lexeo Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lexeo Therapeutics (LXEO) FAQ

Lexeo Therapeutics (LXEO) currently reports a current cash of $72M as of March 2026. That compares with $29M in the prior-year period — up 148.2% year over year. Use the charts on this page to explore Lexeo Therapeutics's current cash history and peer comparisons.

Lexeo Therapeutics's current cash increased from $29M to $72M — a 148.2% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lexeo Therapeutics reported $72M in current cash as of March 2026. That compares with $29M in the prior-year period — up 148.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $72M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lexeo Therapeutics, and consider following LXEO for alerts when major investors trade the stock.